###begin article-title 0
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese
###end article-title 0
###begin p 1
The first two authors contributed equally to this publication.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
To investigate the lysyl oxidase-like 1 (LOXL1) gene for single nucleotide polymorphism (SNP) variations in Japanese patients with exfoliation syndrome (XFS) and exfoliation glaucoma (XFG) and to examine the phenotypes of the patients with these variations.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Fifty-six unrelated Japanese patients with XFS, including 36 patients with XFG, were studied. Genomic DNA was extracted from the leukocytes of peripheral blood, and three SNPs (; p.Arg141Leu, ; p.Gly153Asp, and ) were identified. These SNPs were amplified by polymerase chain reaction (PCR), directly sequenced, and genotyped.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1,</italic>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 609 612 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 625 627 625 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
Two nonsynonymous variants in exon 1 of LOXL1, and , were found to be strongly associated with XFS including XFG. The frequency of the T allele (0.964) in  in eyes with XFS was much higher in controls (0.507) with a p value of 7.7x10-18. The odds ratio for the T allele in  was 26.0 (95% confidence interval, 18.3-37.1). In the haplotype analysis, T-G was overrepresented in XFS subjects (p=7.7x10-18), showing a highly significant difference in frequency between primary open-angle glaucoma (POAG) and the control group (p=0.07), but the G-G and G-A haplotypes were less represented in XFS subjects (p=1.1x10-11 and p=1.0x10-4, respectively). However, an earlier study reported the strongest associated SNP with XFS and XFG, , showed no association.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
SNPs of LOXL1 (; Arg141Leu and ; Gly153Asp) are highly associated with XFS in the Japanese population. However, unidentified genetic or environmental factors independent of LOXL1 will most likely influence the phenotypic expression of the syndrome.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
Exfoliation syndrome (XFS; OMIM ) is a generalized disorder of the extracellular matrix characterized clinically by the pathological accumulation of abnormal fibrillar material in the anterior segment of the eye predisposing the eye to glaucomatous optic neuropathy [1-3]. XFS has also been associated with weakness of the lens zonule fibers, severe chronic open-angle glaucoma, cataract formation, and a spectrum of other serious spontaneous intraocular defects. There is also evidence that XFS is associated with cardiovascular and cerebrovascular morbidity [2,4,5].
###end p 12
###begin p 13
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
The prevalence of XFS varies markedly among populations and is highest in the Scandinavian population and markedly lower in Anglo-Celtic Caucasians [6-9]. The prevalence increases with age and is highest between 70 and 80 years of age [7]. Forty percent of Icelandic individuals 80 years or older in the Reykjavik Eye Study [10] and 22% of the population 70 years or older in the Finnish population were found to have XFS [11]. In the Japanese, the prevalence of XFS is reported to be between 1.1% (XFS with and without glaucoma, and glaucoma suspected of those over 40 years) to 4.8% (XFS with and without glaucoma, and glaucoma suspected of those over 80 years), which is much lower than the prevalence in the Scandinavian population [12,13].
###end p 13
###begin p 14
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 572 577 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
Thorleifsson et al. [14] established a strong association between single nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1 (LOXL1) gene and XFS in the Swedish and Icelandic populations using a genome-wide scan. They identified two nonsynonymous SNPs (; Arg141Leu and ; Gly153Asp) in exon 1 and one intronic SNP () in LOXL1, which conferred an attributable risk of 99% to Icelandic and Swedish individuals [14]. This association was recently confirmed in United States [15-17], Australian [18], and South Indian populations [19]. In addition, the SNPs,  and , of LOXL1 seem to be highly associated with XFS in the Japanese population [20].
###end p 14
###begin p 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
LOXL1 is a member of the lysyl oxidase family of proteins that catalyzes the oxidative deamination of lysine residues of tropoelastin [21]. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein [22], and this family of proteins has important roles in elastogenesis. Thus, it is biologically reasonable that defects in LOXL1 may cause features of XFS because of the aberrant production of elastin and accumulation of fibrillar material in the anterior segment of the eye.
###end p 15
###begin p 16
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
The purpose of this study was to investigate the lysyl oxidase-like 1 (LOXL1) gene for SNP variations in Japanese patients with XFS including those with exfoliation glaucoma (XFG) and compare them to patients with primary open-angle glaucoma (POAG) as well as to examine the phenotypes of the patients with these variations.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 18
###begin p 19
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 51 54 <span type="species:ncbi:9606">men</span>
###xml 62 67 <span type="species:ncbi:9606">women</span>
###xml 115 118 <span type="species:ncbi:9606">men</span>
###xml 126 131 <span type="species:ncbi:9606">women</span>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 638 646 <span type="species:ncbi:9606">patients</span>
Fifty-six unrelated Japanese patients with XFS (31 men and 25 women; mean age 74.75+/-6.15 years) including 36 (23 men and 13 women) patients with XFG were studied. All of the patients resided in the northern part of Japan and were examined at the Ophthalmic clinic of the Tohoku University Hospital (Sendai, Japan). The purpose and procedures were explained to all patients, and an informed consent was obtained from each of them. This study was approved by the Tohoku University Institutional Review Board, and the procedures conformed to the tenets of the Declaration of Helsinki. Routine ophthalmic examinations were performed on all patients.
###end p 19
###begin p 20
###xml 37 44 <span type="species:ncbi:9606">patient</span>
###xml 179 187 <span type="species:ncbi:9606">Patients</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
###xml 746 749 <span type="species:ncbi:9606">men</span>
###xml 757 762 <span type="species:ncbi:9606">women</span>
###xml 1076 1084 <span type="species:ncbi:9606">patients</span>
The criterion used for classifying a patient as having XFS was an open anterior chamber angle with accumulation of abnormal fibrillar material in the anterior segment of the eye. Patients who were diagnosed with XFG met the criterion of XFS and also had 1) applanation intraocular pressure (IOP) greater than 22 mmHg in each eye, 2) glaucomatous cupping in each eye including a cup-to-disc ratio greater than 0.7, and 3) presence of visual field defects determined by Goldmann perimetry and/or Humphrey field analyzer consistent with the glaucomatous cupping in at least one eye. The mean IOP at diagnosis was 35.0+/-12.0 mmHg in the 36 patients with XFG and 17.9+/-6.7 mmHg in the 20 patients with XFS but without glaucoma. Control subjects (76 men and 62 women; mean age 68.0+/-7.7 years) had the following characteristics 1) no accumulation of abnormal fibrillar material in the anterior segment of the eye, 2) IOP less than 22 mmHg, 3) normal optic discs, and 4) no family history of glaucoma. The mean IOP at the initial examination was 14.3+/-3.4 mmHg in the138 control patients.
###end p 20
###begin p 21
###xml 751 753 739 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 873 875 861 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Genomic DNA was extracted from peripheral blood leukocytes and purified with the Qiagen QIAamp Blood Kit (Qiagen, Valencia, CA), and the three SNPs (, , and ) were amplified by polymerase chain reaction (PCR), directly sequenced, and genotyped. For PCR, two primer sets (for  and  in exon 1: 5'-CTC AGC GCT CCG AGA GTA G-3' and 5'-ACA CGA AAC CCT GGT CGT AG-3'; for  in intron 1: 5'-ACC AGG TAC TTG CAG CAT CC-3' and 5'-TGC TTG CCT AAT CAC AGC AC-3') were used under standard PCR conditions. The amplifications were performed at 60degrees C annealing temperature for the two SNPs in exon 1 and 58degrees C annealing temperature for the two SNPs in intron 1. The PCR fragments were purified by ExoSAP-IT (USB, Cleveland, OH) and sequenced by the BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City, CA) on an automated DNA sequencer (ABI PRISMTM 3100 Genetic Analyzer, Perkin-Elmer).
###end p 21
###begin p 22
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 190 191 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
The allelic frequencies, genotypes, and haplotypes of the patients with the LOXL1 SNPs were determined. The allelic and genotypic frequencies were compared with two-tailed p values using chi2 analyses.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 7 8 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 255 260 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 647 649 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 746 747 742 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 865 866 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The chi2 test, depending on cell counts, was used to determine if the genotype frequency differences between the cases and controls were significant. Odds ratios (approximating to relative risk) were calculated as a measure of the association between the LOXL1 genotype and the phenotype of XFS. For each odds ratio, the p values and 95% confidence intervals were calculated. The inferred haplotypes, quantified between all pairs of biallelic loci, were estimated using the SNPAlyze program version 4.0 (Dynacom, Yokohama, Japan). Additionally, a permutation test was performed to test the deviation of allelic frequencies of SNPs and haplotypes [23]. The significance of the association was determined by contingency table analysis using the chi2 test. The Hardy-Weinberg equilibrium was analyzed using gene frequencies obtained by simple gene counting and the chi2 test with Yates' correction for comparing observed and expected values.
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
The allelic frequencies, genotypes, and haplotypes of the three LOXL1 SNPs (, p.Arg141Leu; , p.Gly153Asp; and  in intron 1) were determined in the cohort of subjects from the northern region of Japan.
###end p 26
###begin title 27
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Distribution of LOXL1 variants in exfoliation syndrome patients and control subjects
###end title 27
###begin p 28
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 174 176 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 192 199 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
The T allele of the  SNP was detected at a significantly higher frequency in patients with XFG and XFS without glaucoma than in the control subjects (p=1.7x10-12 and p=1.5x10-8, respectively; Table 1). Similarly, all of the XFS subjects had the G allele of  SNP. The G allele was also associated with XFG and XFS without glaucoma (p=5.2x10-3 and p=0.027, respectively).
###end p 28
###begin title 29
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
LOXL1 allelic frequencies of  and  in Japanese patients with exfoliation syndrome and controls.
###end title 29
###begin p 30
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 261 262 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The single asterisk indicates the data were reported by Hayashi et al. [20], and the double asterisk denotes that the data were reported by Thorleifsson et al. [14]. The significance of the associatio was determined by a contingency table analysis using the chi2 test. CI=confidence interval; N/A=Not applicable in the original report.
###end p 30
###begin p 31
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;19</sup>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
The genotypic frequencies for each of the two LOXL1 SNPs were compared between XFS patients and control subjects (Table 2). The frequency of the T/T variant in the  SNP was significantly higher in XFS patients than in control subjects (94.6% versus 21.7%), but the frequency of the T/G variant was significantly lower in the XFS patients than control subjects (3.6% versus 58.0%; p=1.6x10-19). There was no statistical difference between patients with POAG and control subjects.
###end p 31
###begin title 32
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Frequency of genotypes, p.R141L, p. G153D, and , of LOXL1 in patients with XFS, XFG, and control subjects.
###end title 32
###begin p 33
###xml 124 125 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The asterisk indicates that the significance of the association was determined by a contingency table analysis using the chi2 test.
###end p 33
###begin p 34
###xml 148 150 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
All of the patients with XFS had the G/G variant of , which was higher in the XFS patients than in the control subjects (100% versus 78.3%; p=7.5x10-4). There was no significant difference between POAG patients and control subjects.
###end p 34
###begin p 35
###xml 201 208 201 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
Interestingly, there was no statistically significant difference between XFS and XFG patients in the allelic frequencies of  (p>0.05), and all the genotypes for  were G-G in both XFS and XFG patients (Table 1). The strongest association of the SNPs with XFS was for the T allele of , as in the original report [14]. However, there was no statistical difference between XFS, XFG, and controls in the allelic frequency of  (Table 2). All SNPs adhered to the Hardy-Weinberg expectations (p>0.05).
###end p 35
###begin title 36
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Haplotype analysis of LOXL1 in the Japanese population
###end title 36
###begin p 37
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 378 385 378 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 544 546 544 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 773 779 773 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table3</xref>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
###xml 714 722 <span type="species:ncbi:9606">patients</span>
###xml 728 736 <span type="species:ncbi:9606">patients</span>
###xml 746 754 <span type="species:ncbi:9606">patients</span>
The inferred haplotypes between all pairs of biallelic loci were estimated (Table 3). Two SNPs,  and , were significantly associated with XFS (p<0.05). The haplotype-based associations were tested with a 1,000 iterated permutation test. Three major haplotypes, G-G, T-G, and G-A (each frequency greater than 5%), were found in the subjects, but the T-A haplotype was not found (Table 3). The T-G haplotype was overrepresented in all XFS patients, XFG patients, and XFS patients that did not have glaucoma (p=7.7x10-18, p=1.7x10-12, and p=1.5x10-8, respectively), showing a highly significant difference in frequency from the POAG and control groups, but the G-G and G-A haplotypes were less represented in all XFS patients, XFG patients, and XFS patients without glaucoma (Table3).
###end p 37
###begin title 38
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 20 28 <span type="species:ncbi:9606">patients</span>
LOXL1 haplotypes in patients with exfoliation syndrome and in controls.
###end title 38
###begin p 39
The inferred haplotypes, quantified between all pairs of biallelic loci, were estimated using the SNPAlyze program version 4.0 (Dynacom, Yokohama, Japan).
###end p 39
###begin title 40
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Phenotypes of exfoliation glaucoma patients in our population
###end title 40
###begin p 41
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 265 272 <span type="species:ncbi:9606">patient</span>
###xml 288 291 <span type="species:ncbi:9606">man</span>
The phenotypes of our 36 XFG patients were high IOP (35.0+/-12.0 mmHg), poor response to topical medication (number of eye drops; 2.4+/-0.4 bottles), aggressive course without treatment, and moderate response to filtration surgery. Among the XFS subjects, only one patient, a 76-year-old man with XFG, had a unique haplotype of G-G.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
We confirmed the findings of Thorleifsson and colleagues [14] that two coding SNPs in LOXL1 were strongly associated with XFS in our Japanese population. In recent studies, the frequencies of LOXL1 SNP alleles, genotypes, and haplotypes detected in cohorts in Iowa and Australian were remarkably similar to those reported in Scandinavian populations [15,18]. The G allele of each of the LOXL1 SNPs was highly associated with XFS, and the risk for disease in those populations was associated most strongly with the G-G haplotype.
###end p 43
###begin p 44
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 689 696 689 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
However, the distribution of the  alleles and haplotypes in patients were quite different between Scandinavian, Australian, American, and Japanese subjects. In the Northern Japanese in this study, the T allele of the  SNP was dominant in controls, and more than 90% of XFS subjects had the T allele. These results reconfirmed the previous study in the Japanese population derived from the western part of Japan [20]. The frequency and position of the SNPs are different among various populations. So, it is difficult to apply the genome information of a polymorphism of Caucasians to that of East Asians. However, as for the Japanese population, the genetic background is homogeneous, and Table 1 showed the similarity between the Japanese population.
###end p 44
###begin p 45
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
In general, Japanese patients with XFG associated with a LOXL1 SNP show late-onset of glaucoma after 65 years of age. XFG would be a relatively uncommon age-related disease characterized by a generalized fibrillar degeneration of elastin-containing tissues. In our study, the age at onset was mainly older than 60 years of age (two case showed an onset of 55 and 58 years). The phenotypes of our XFG patients with the two variants were high IOP, poor response to topical medication, aggressive course without treatment, and probably moderate response to filtration surgery.
###end p 45
###begin p 46
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 831 836 831 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 370 378 <span type="species:ncbi:9606">patients</span>
Recently, the most promising locus for diagnosing XFS was assigned to 18q12.1-21.33, and the susceptible loci were proposed to be 2q, 17p, and 19q in the Finnish population in an autosomal dominant mode of inheritance with incomplete penetrance [24]. In a microarray study, it was reported that the differentially expressed genes with a high level of reproducibility in patients with XFS were mainly related to extracellular matrix metabolism and cellular stress [25]. Hewitt et al. [18] described a remarkably similar LOXL1 allelic architecture in the Blue Mountains Eye Study (BMES) where XFS is a relatively uncommon disease compared to that in Australia and to that of the Nordic population in which the XFS is extremely common. This strongly suggests that an as yet unidentified genetic or environmental factor independent of LOXL1 strongly influences the phenotypic expression of the syndrome.
###end p 46
###begin p 47
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
High risk LOXL1 haplotypes account for a significant fraction of patients with XFS and thus may be useful in genetic screening tests. However, because many patients that carry LOXL1 risk alleles do not have XFS, genetic testing for these alleles may be of limited usefulness at present. An unaffected control group with the highest risk diplotype (50%) would be expected to contain affected but not yet diagnosed individuals with XFS. Identification of XFS-associated SNPs of such magnitude that is clearly identifiable will allow early detection even before elevation of IOP at a later age or irreversible visual impairment due to damage of the optic nerve. More studies of the functions and genotype-phenotype correlation of LOXL1 are required to determine the pathophysiology of XFS, and more studies such as meta-analysis with a greater number of subjects would be needed to confirm these genetic data.
###end p 47
###begin title 48
Acknowledgments
###end title 48
###begin p 49
This study was supported in part by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government (N.F.; C-18591905), Tokyo, Japan. This study was supported by a grant to N.F. from the Suda Memorial Fund for Glaucoma Research. The authors thank Dr. Takashi Shiono, Dr. Yoshihiko Imai, Dr. Sei-ichi Watanabe, and Dr. Kumiko Sato for collecting the samples. The authors thank Dr. Duco I. Hamasaki for editing the manuscript.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
Lindberg and the discovery of exfoliation syndrome.
###end article-title 51
###begin article-title 52
Ocular and systemic pseudoexfoliation syndrome.
###end article-title 52
###begin article-title 53
Exfoliation syndrome: prevalence and inheritance in a subisolate of the Finnish population.
###end article-title 53
###begin article-title 54
Association of pseudoexfoliation syndrome with increased vascular risk.
###end article-title 54
###begin article-title 55
Pseudoexfoliation and aortic aneurysms.
###end article-title 55
###begin article-title 56
Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos, and Russians.
###end article-title 56
###begin article-title 57
Exfoliation syndrome in various ethnic populations.
###end article-title 57
###begin article-title 58
Epidemiology of glaucoma in northern Europe.
###end article-title 58
###begin article-title 59
The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study.
###end article-title 59
###begin article-title 60
Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study.
###end article-title 60
###begin article-title 61
Prevalence and risk factors of lens opacities in the elderly in Finland. A population-based study.
###end article-title 61
###begin article-title 62
The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population.
###end article-title 62
###begin article-title 63
The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study.
###end article-title 63
###begin article-title 64
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
###end article-title 64
###begin article-title 65
###xml 60 68 <span type="species:ncbi:9606">patients</span>
LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.
###end article-title 65
###begin article-title 66
Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.
###end article-title 66
###begin article-title 67
DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.
###end article-title 67
###begin article-title 68
###xml 138 144 <span type="species:ncbi:9606">people</span>
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.
###end article-title 68
###begin article-title 69
Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.
###end article-title 69
###begin article-title 70
Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population.
###end article-title 70
###begin article-title 71
The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers.
###end article-title 71
###begin article-title 72
Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.
###end article-title 72
###begin article-title 73
Model-free analysis and permutation tests for allelic associations.
###end article-title 73
###begin article-title 74
Genome-wide scan of exfoliation syndrome.
###end article-title 74
###begin article-title 75
Differential gene expression in pseudoexfoliation syndrome.
###end article-title 75

